Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Healthtrust
UBS
US Army
McKesson
McKinsey
AstraZeneca
Argus Health
Boehringer Ingelheim
Merck

Generated: June 23, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 088769

« Back to Dashboard

NDA 088769 describes MEPIVACAINE HYDROCHLORIDE, which is a drug marketed by Belmora Llc, Hospira Inc, Intl Medication Sys, and Watson Labs, and is included in six NDAs. Additional details are available on the MEPIVACAINE HYDROCHLORIDE profile page.

The generic ingredient in MEPIVACAINE HYDROCHLORIDE is levonordefrin; mepivacaine hydrochloride. There are two drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the levonordefrin; mepivacaine hydrochloride profile page.
Summary for 088769
Tradename:MEPIVACAINE HYDROCHLORIDE
Applicant:Watson Labs
Ingredient:mepivacaine hydrochloride
Patents:0
Formulation / Manufacturing:see details
Medical Subject Heading (MeSH) Categories for 088769

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:INJECTABLE;INJECTIONStrength1%
Approval Date:Nov 20, 1984TE:RLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chubb
Cerilliant
Johnson and Johnson
Moodys
UBS
Argus Health
AstraZeneca
Mallinckrodt
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.